Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2016098112) NOVEL CONDOM COMPRISING CANNABIS DERIVED COMPOSITIONS FOR ENHANCEMENT OF SEXUAL PLEASURE AND DECREASE OF ERECTILE DYSFUNCTION SYMPTOMS
Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

Claims.

1. A condom for providing increased protection from STI's including HIV and Hepatitis comprising a biocompatible material or composition for forming at least part of the structure of a condom, wherein said biocompatible material or composition incorporates cannabis or cannabis derived compositions; and further wherein said condom is adapted to increase the pleasure felt when compared to the pleasure felt when performing the same action but in absence of the present invention, measured using standard scales determined in sexology psychodiagnostic reactives.

2. A condom for providing increased protection from STI's including HIV and Hepatitis comprising a biocompatible material or composition for forming at least part of the structure of a condom, wherein said biocompatible material or composition incorporates cannabis or cannabis derived compositions; and further wherein said condom is adapted to increase the pleasure felt when compared to the pleasure felt when performing the same action but in absence of the present invention, measured using functional MRI methods.

3. The condom according to claims 1 and 2, wherein said condom is substantially made of latex.

4. The condom according to claims 1 and 2, wherein said condom is substantially made of a material selected from the group consisting of latex, polyurethane, polyisoprene, nitrile, lamb intestine or any combination thereof.

5. The condom of claims 1 and 2, wherein said condom is a male condom.

6. The condom of claims 1 and 2, wherein said condom is a female condom.

7. The condom of claims 1 and 2, wherein said condom complies with essential performance attributes of ISO 4074 Natural Latex condoms requirements and test methods.

8. The condom of claims 1 and 2, wherein said biocompatible material complies with ISO 10993-1.

9. The condom of claims 1 and 2, wherein the cytotoxicity of said biocompatible material complies with ISO 10993-5.

10. The condom of claims 1 and 2, wherein the irritation and sensitization values of said biocompatible material complies with ISO 10993-10.

11. The condom of claims 1 and 2, wherein the water extractable level for soluble proteins is less than 200 ug/g as measured by the Lowry method.

12. The condom of claims 1 and 2, wherein said cannabis or cannabis derived compositions adapted to provide activation of neurological pathways during use thereby enhancing sensation.

13. The condom of claims 1 and 2, wherein the lubricant of said condom comprises cannabis or cannabis derived compositions.

14. The condom of claim 13, wherein said lubricant of said condom additionally comprises silicone fluid.

15. The condom of claim 13, wherein said lubricant of said condom additionally comprises glycol or a water based lubricant.

16. The condom of claims 1 and 2, wherein said cannabis or cannabis derived compositions can be applied to said condom on the inside, the outside or both.

17. The condom of claims 1 and 2, wherein said condom additionally comprises nonoxynol-9 as a spermicide.

18. The condom of claims 1 and 2, wherein said condom additionally comprises a bactericide, viricide or spermicide or any combination thereof.

19. A biocompatible material or composition for forming at least part of the structure of a condom, wherein said biocompatible material or composition incorporates cannabis or cannabis derived compositions and provides enhanced protection from STI's when compared with said biocompatible material without said incorporation of cannabis or cannabis derived compositions.

20. The biocompatible material or composition adapted for ex tempora application as a cream, gel or foam on any conventional condom.

21. A condom for treating erectile dysfunction disorder comprising a biocompatible material or composition for forming at least part of the structure of a condom, wherein said biocompatible material or composition incorporates cannabis or cannabis derived compositions.

22. The condom of claims 1 and 2, further comprising an additive comprising (a) cannabis or cannabis derived compositions, (b) at least one

pharmaceutically acceptable carrier or excipient, wherein said composition is adapted to be penile or vaginally administrable further wherein said composition is in an immediate release form.

23. The condom of claim 22, wherein said carrier or excipient is selected from a group consisting of diluents, binders, granulating agents, glidants, lubricants, surfactants, disintegrates, dissolving agents, solubilising agents, bioadhesive agents, polysaccharides, polymers, copolymers, bioavailability enhancing agent, acidifying agents, probiotic agents, protective agents, antioxidants, dispersing agents and any combination thereof.

24. The condom of claim 22, wherein said composition has disintegration time of between about 3 minutes and about 10 minutes in the penis or vagina.

25. The condom of claim 22, wherein said additive can be applied to the inside, the outside or both.

26. A condom for providing increased protection from STI's including HIV and Hepatitis, further providing enhanced pleasure, comprising an additive comprising (a) cannabis or cannabis derived compositions, (b) at least one pharmaceutically acceptable carrier or excipient, wherein said additive is adapted to be penile or vaginally administrable further wherein said additive is in an immediate release form, prepared by steps of:

a. preparing a mixture comprising (i) an effective amount of at least one active ingredient selected from a group consisting of cannabis or cannabis derived compositions, and (ii) at least one pharmaceutically acceptable carrier or excipient and,

b. forming said additive in an immediate release form.

c. applying said additive to said condom.

27. An additive for penile or vaginal administration prepared by steps according to claim 26, wherein said mixture additionally comprises a lubricating agent.

28. An additive for penile or vaginal administration prepared by steps according to claim 26, wherein said composition is further prepared by steps of incorporating into said mixture at least one carrier or excipient selected from a group consisting of diluents, binders, granulating agents, glidants, lubricants, surfactants, disintegrates, dissolving agents, solubilising agents, bioadhesive agents, polysaccharides, polymers, copolymers, bioavailability enhancing agent, acidifying agents, probiotic agents, protective agents, antioxidants, dispersing agents, add-on" formulation excipients and any combination thereof.

29. Use of a penile or vaginally administrable additive, for the manufacture of a pleasure enhancer condom, said additive comprising (a) cannabis or cannabis derived compositions, (b) at least one pharmaceutically acceptable carrier or excipient, wherein said additive is adapted to be penile or vaginally administrable further wherein said additive is in an immediate release form.

30. The use of claim 29, wherein said composition is further prepared by steps of incorporating into said mixture at least one carrier or excipient selected from a group consisting of diluents, binders, granulating agents, glidants, lubricants, surfactants, disintegrates, dissolving agents, solubilizing agents, bioadhesive agents, polysaccharides, polymers, copolymers, bioavailability enhancing agent, acidifying agents, probiotic agents, protective agents, antioxidants, dispersing agents, add-on" formulation excipients and any combination thereof.

31. Use of a penile or vaginally administrable additive, for the manufacture of a medicament for the treatment of erectile dysfunction disorder, said additive comprising (a) cannabis or cannabis derived compositions, (b) at least one pharmaceutically acceptable carrier or excipient, wherein said additive is adapted to be penile or vaginally administrable further wherein said additive is in an immediate release form.

32. The use of claim 29, wherein said composition is further prepared by steps of incorporating into said mixture at least one carrier or excipient selected from a group consisting of diluents, binders, granulating agents, glidants, lubricants, surfactants, disintegrates, dissolving agents, solubilizing agents, bioadhesive agents, polysaccharides, polymers, copolymers, bioavailability enhancing agent, acidifying agents, probiotic agents, protective agents, antioxidants, dispersing agents, add-on" formulation excipients and any combination thereof.